Headline News about Bristol-Myers Squibb
What Analysts Are Saying About Bristol-Myers Squibb Stock
September 16, 2024
Via Benzinga
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Via Benzinga
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Via Benzinga
Exposures
Product Safety
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|